1
/
의
1
ELK Biotechnology
SKU(재고 관리 코드):ELK8057
Human Anti-MBL(Anti-Mannose Binding Lectin Antibody) ELISA Kit
Human Anti-MBL(Anti-Mannose Binding Lectin Antibody) ELISA Kit
Human Anti-MBL(Anti-Mannose Binding Lectin Antibody) ELISA Kit
Overview
| Product name: | Human Anti-MBL(Anti-Mannose Binding Lectin Antibody) ELISA Kit |
| Reactivity: | Human |
| Alternative Names: | MBL2; COLEC1; HSMBPC; MBP1; MBP; Collectin-1; Mannose-binding protein C; Mannan Binding Protein; Mannose-Binding Lectin(Protein C)2,Soluble(Opsonic Defect) |
| Assay Type: | Sandwich |
| Sensitivity: | 2.45 ng/mL |
| Standard: | 400 ng/mL |
| Detection Range: | 6.25-400 ng/mL |
| Sample Type: | Serum, plasma and other biological fluids |
| Assay Length: | 3.5h |
| Research Area: | Signal transduction;Infection immunity;Immune molecule; |
| Test principle: | The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human Anti-MBL. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human Anti-MBL. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human Anti-MBL, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human Anti-MBL in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 400.00 | 2.126 | 2.037 |
| 200.00 | 1.674 | 1.585 |
| 100.00 | 1.174 | 1.085 |
| 50.00 | 0.912 | 0.823 |
| 25.00 | 0.548 | 0.459 |
| 12.50 | 0.305 | 0.216 |
| 6.25 | 0.156 | 0.067 |
| 0.00 | 0.089 | 0.000 |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant Anti-MBL and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-MBL in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 85-99% | 92% |
| EDTA plasma(n=5) | 83-95% | 89% |
| Heparin plasma(n=5) | 96-107% | 102% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-MBL and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 96-105% | 95-103% | 95-103% | 87-98% |
| EDTA plasma(n=5) | 83-98% | 92-103% | 86-97% | 93-101% |
| Heparin plasma(n=5) | 87-96% | 86-98% | 91-103% | 87-90% |
Share
